NIH NCATS E-Newsletter: September 2020

Volume 09 │ Issue 09│ September 30, 2020

DIRECTOR’S MESSAGE

In his latest message, the director discusses two recent
examples of NCATS’ innovative approach to clinical trials:
convalescent plasma trials for COVID-19 and the new tissue
chips program,“Clinical Trials on a Chip.”

Read More

WHAT’S HAPPENING

CTSA Program Plays Key Role in Expansion of Two Rigorous Convalescent Plasma Clinical Trials

New Clinical Trials on a Chip Program Aims to Improve Drug Development Process Use COVID-19 Data from the N3C Data Enclave: A National Data Analytics Platform
Quantum Dot Probe Reveals How SARS-CoV-2 Infects Human Cells in Real Time Video: Exploring New Avenues to Enhance the CTSA Program

ANNOUNCEMENTS & OPPORTUNITIES
Funding Opportunity: Multi-Disciplinary Diagnostic Strategies for Rare Diseases Submit applications by November 12, 2020 Save the Date: Virtual Workshop on AAV-Mediated Gene Therapy Meeting Register before November 30, 2020 New ASPIRE Reduction-to-Practice Challenge is Open Apply between November 30 and February 28, 2021
Funding Opportunities Collaborate with NCATS Scientists

MEET NCATS STAFF
Jean Dehdashti, M.Sc., RAC Gregory J. Tawa, Ph.D.

Jean Dehdashti, M.Sc., RAC

is a health program specialist in the NCATS Office of the Director.

Gregory J. Tawa, Ph.D.

is the modeling and informatics lead for the
Therapeutic Development Branch within NCATS’ Division of Preclinical Innovation.

Learn more about these and other staff members >

CONTACT US

National Center for Advancing Translational Sciences
National Institutes of Health
6701 Democracy Boulevard, 9th Floor
Bethesda, MD 20892

For language access assistance, contact the NCATS Public Information Officer.

To view previous newsletters, click here.

 

Share this:

View all posts